refractory multiple myeloma patients treated with lenalidomide

Overview of attention for article published in Journal of Hematology & Oncology, November 2016

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
Average Attention Score compared to outputs of the same age and source

So far, Altmetric has seen 7 X posts from 5 X users, with an upper bound of 29,939 followers.

RT @Myeloma_Doc: High IKZF1/3 expression is a favorable prognostic factor for relapsed/refractory #myeloma pts treated w/ #Revlimid: https:…

RT @Myeloma_Doc: High IKZF1/3 expression is a favorable prognostic factor for relapsed/refractory #myeloma pts treated w/ #Revlimid: https:…

High IKZF1/3 a favorable prognostic factor in myeloma https://t.co/4TgXBN4o1v

RT @Myeloma_Doc: High IKZF1/3 expression is a favorable prognostic factor for relapsed/refractory #myeloma pts treated w/ #Revlimid: https:…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.